Medicare Enrolled

Dr. Andres Endara-Bravo, M.D.

Pulmonary Disease · Orlando, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1222 S ORANGE AVE, Orlando, FL 32806
3218417856
In practice since 2007 (18 years)
NPI: 1972795599 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Endara-Bravo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Endara-Bravo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Endara-Bravo

Dr. Andres Endara-Bravo is a pulmonary disease in Orlando, FL, with 18 years in practice. Based on federal Medicare data, Dr. Endara-Bravo performed 1,276 Medicare services across 1,027 unique beneficiaries.

Between the years covered by Open Payments, Dr. Endara-Bravo received a total of $14,023 from 42 pharmaceutical and/or device companies across 352 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Endara-Bravo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 46% volume in FL$ $14,023 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,276
Medicare services
Top 46% in FL for pulmonary disease
1,027
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~71 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)354$100$382
New patient office visit (45-59 min)245$129$500
Office visit, established patient (20-29 min)145$70$270
Hospital follow-up visit, moderate complexity80$64$240
New patient office visit (30-44 min)68$90$337
Evaluation of use of breathing device65$13$50
Test to measure expiratory airflow and volume changes before and after medication administration58$8$31
Test to examine how well the lungs exchange gases56$7$27
Test to determine lung volumes using gas dilution or washout47$10$36
Sleep study in sleep lab (6 years or older)43$94$353
Hospital follow-up visit, high complexity31$87$361
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes24$68$255
Initial hospital admission, moderate complexity19$103$396
Irrigation and suction of lung airways to obtain cells using an endoscope15$58$403
Test to measure expiratory airflow and volume14$7$25
Sleep study in sleep lab with continuous airway pressure (6 years or older)12$98$366
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,023
Total received (2018-2024)
Avg $2,003/year across 7 years
Top 15% in FL for pulmonary disease
42
Companies
352
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,797 (69.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,226 (30.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$712
2023
$5,876
2022
$928
2021
$656
2020
$1,417
2019
$1,821
2018
$2,613

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Intuitive Surgical, Inc.
$3,926
AstraZeneca Pharmaceuticals LP
$2,414
GlaxoSmithKline, LLC.
$1,626
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,016
Olympus Corporation of the Americas
$754
Philips Electronics North America Corporation
$721
Jazz Pharmaceuticals Inc.
$348
Mylan Specialty L.P.
$321
Sunovion Pharmaceuticals Inc.
$282
CSL Behring
$230
HARMONY BIOSCIENCES LLC
$226
Novartis Pharmaceuticals Corporation
$210
Inspire Medical Systems, Inc.
$201
GENZYME CORPORATION
$161
Grifols USA, LLC
$156
Genentech USA, Inc.
$143
Amgen Inc.
$134
Ethicon Inc.
$119
Novo Nordisk Inc
$100
Actelion Pharmaceuticals US, Inc.
$98
Regeneron Healthcare Solutions, Inc.
$96
Shire North American Group Inc
$74
Teva Pharmaceuticals USA, Inc.
$70
ADVANCED RESPIRATORY, INC
$62
United Therapeutics Corporation
$54
Paratek Pharmaceuticals, Inc.
$52
JAZZ PHARMACEUTICALS INC.
$46
Mallinckrodt Hospital Products Inc.
$45
Advanced Respiratory, Inc
$39
Mallinckrodt LLC
$33
Electromed, Inc.
$33
Phadia US Inc.
$30
Takeda Pharmaceuticals U.S.A., Inc.
$28
Pulmonx Corporation
$27
Veran Medical Technologies, Inc.
$24
Tactile Systems Technology Inc
$23
Vifor Pharma, Inc.
$22
Philips North America LLC
$19
Harmony Biosciences Llc
$18
Harmony Biosciences LLC
$17
Insmed, Inc.
$16
INOGEN, INC.
$12
Top 3 companies account for 56.8% of total payments
Associated products mentioned in payments ›
(2809) Trilogy 100 · (8744) Trilogy Evo · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · ANORO · ANORO ELLIPTA · AREXVY · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHARTIS CATHETER · CINQAIR · DUPIXENT · Da Vinci Surgical System · DreamStat Cpap Auto · Esbriet · FASENRA · Flexitouch Plus · GLASSIA · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · ION · ImmunoCAP · LONHALA MAGNAIR · Life 2000 Ventilation System · Monarch Platform · NONE · NUCALA · NUZYRA · OFEV · ORENITRAM · Ozempic · Perforomist · Prolastin-C Liquid · Respiratoriy Care Undiv · SEEBRI NEOHALER · SINGLE USE SUCTION VALVE (Sterile) · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · TEZSPIRE · TRELEGY ELLIPTA · The Vest System Model 105 Home Care · The VisiVest Airway Clearance System · Trilogy 100 · UTIBRON NEOHALER · Utibron · WAKIX · Wakix · Wellcentive Undiv · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (70%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,099 per 100 Medicare services performed
Looking for a pulmonary disease in Orlando?
Compare pulmonary diseases in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
50
Per 100K population
3.5
County median income
$77,011
Nearest hospital
ORLANDO HEALTH
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Endara-Bravo is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 15%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Endara-Bravo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Endara-Bravo performed 354 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Endara-Bravo receive payments from pharmaceutical companies?
Yes. Dr. Endara-Bravo received a total of $14,023 from 42 companies across 352 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Endara-Bravo's costs compare to other pulmonary diseases in Orlando?
Dr. Endara-Bravo's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Endara-Bravo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →